Page last updated: 2024-10-28

hydralazine and ADPKD

hydralazine has been researched along with ADPKD in 1 studies

Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.

Research Excerpts

ExcerptRelevanceReference
" However, although chronic enalapril and hydralazine protect against the loss of renal function, only enalapril limits renal growth and proteinuria, and neither significantly limits tubulointerstitial fibrosis."3.70Hypertension and renal injury in experimental polycystic kidney disease. ( Al-Nimri, MA; Anderson, S; Chapman, JG; Kelly, FJ; Kennefick, TM; Oyama, TT; Thompson, MM, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kennefick, TM1
Al-Nimri, MA1
Oyama, TT1
Thompson, MM1
Kelly, FJ1
Chapman, JG1
Anderson, S1

Other Studies

1 other study available for hydralazine and ADPKD

ArticleYear
Hypertension and renal injury in experimental polycystic kidney disease.
    Kidney international, 1999, Volume: 56, Issue:6

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Enalapril; Fibrosis; Hydralazine; Hypertension, Re

1999